Pacific Biosciences of California (PACB) Fair Value & DCF
Score
PACB fair value $4.35. Price $1.96. Price is 55% below fair value.
Worked example
No cash-flow value. Free cash flow is not steady enough to discount.
Earnings value. Next-twelve-months earnings per share of $0.17 times 25.62 is $4.35. The peer group is Medical - Devices, 11 companies worth at least $10 billion. This stock has no 10-year median P/E, so the peer median of 25.6 is kept between 8 and 30, which is 25.62.
Fair value is the earnings value, $4.35. The price is $1.96, which is 55.0% below fair value.